Bourse
Stock filings

BLSM insider trades & Congress trades

BlossomHill Therapeutics, Inc.: public insider filings and Congress disclosures, in one place.

7insider buys + sells
0Congress trades
6 / 0insider buys / sells, 90 days
Aug 10, 2026latest buying cluster

Bourse has recorded 7 open-market insider transactions in BlossomHill Therapeutics, Inc. (BLSM) (7 purchases with code P and 0 sales with code S), the most recent on August 10, 2026.

In the last 90 days: 6 purchases by 6 insiders ($25.1M) and 0 sales by 0 ($0).

The most recent insider buying cluster (three or more different insiders buying within 14 days) ran from August 10, 2026 to August 10, 2026, with 6 insiders.

Insider transactions

SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.

DateInsiderRoleTypeSharesPriceValueAfter 1M
Aug 10, 2026Liptak Vincent PaulGeneral CounselBuy2,200$16.00$35K+0.4%
Aug 10, 2026Keyes Jason AChief Financial OfficerBuy700$16.00$11K+0.4%
Aug 10, 2026Chen BihuaCEO and ChairpersonBuy312,500$16.00$5.00M+0.4%
Aug 10, 2026Schmid John P.–Buy6,000$16.00$96K+0.4%
Aug 10, 2026Orbimed Advisors Llc–Buy625,000$16.00$10.0M+0.3%
Aug 10, 2026Gordon Carl L–Buy625,000$16.00$10.0M+0.3%
Aug 7, 2026Liptak Vincent PaulGeneral CounselBuy2,500$15.80$40K+0.4%

Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.

New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.

See these filings as they land

Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.

Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.